[HTML][HTML] Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
…, S Brünink, J Schneider, ML Schmidt… - …, 2020 - eurosurveillance.org
Background The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV)
poses a challenge for public health laboratories as virus isolates are unavailable while there …
poses a challenge for public health laboratories as virus isolates are unavailable while there …
Estimating infectiousness throughout SARS-CoV-2 infection course
…, T Bleicker, J Tesch, ML Schmidt… - Science, 2021 - science.org
INTRODUCTION Although post facto studies have revealed the importance of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from presymptomatic, …
respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from presymptomatic, …
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort …
…, LJ Lippert, P Tscheak, ML Schmidt… - The Lancet …, 2021 - thelancet.com
Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …
[PDF][PDF] A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model
…, D Schmitz, LM Jeworowski, A Richter, ML Schmidt… - Cell, 2020 - cell.com
The emergence of SARS-CoV-2 led to pandemic spread of coronavirus disease 2019 (COVID-19),
manifesting with respiratory symptoms and multi-organ dysfunction. Detailed …
manifesting with respiratory symptoms and multi-organ dysfunction. Detailed …
[HTML][HTML] Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
Background Antigen point-of-care tests (AgPOCTs) can accelerate SARS-CoV-2 testing. As
some AgPOCTs have become available, interest is growing in their utility and performance. …
some AgPOCTs have become available, interest is growing in their utility and performance. …
SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
…, M Ramberger, W Yu, Y Hua, H Tien, ML Schmidt… - Science, 2022 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant of concern (VOC)
resists neutralization by major classes of antibodies from COVID-19 patients and …
resists neutralization by major classes of antibodies from COVID-19 patients and …
[HTML][HTML] Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
…, A Schmandke, ML Schmidt, TH Schmidt… - Nature …, 2021 - nature.com
To estimate the seroprevalence and temporal course of SARS-CoV-2 neutralizing antibodies,
we embedded a multi-tiered seroprevalence survey within an ongoing community-based …
we embedded a multi-tiered seroprevalence survey within an ongoing community-based …
[HTML][HTML] Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
…, X Fan, M Bekliz, M Essaidi-Laziosi, ML Schmidt… - Nature, 2022 - nature.com
Emerging variants of concern (VOCs) are driving the COVID-19 pandemic 1 , 2 . Experimental
assessments of replication and transmission of major VOCs and progenitors are needed …
assessments of replication and transmission of major VOCs and progenitors are needed …
Genetic variability, including gene duplication and deletion, in early sequences from the 2022 European monkeypox outbreak
…, T Veith, J Beheim-Schwarzbach, J Tesch, ML Schmidt… - Biorxiv, 2022 - biorxiv.org
Genome sequences from 47 monkeypox virus infections detected in a German university
virology laboratory were analyzed in context of other sequences from the 2022 outbreak and …
virology laboratory were analyzed in context of other sequences from the 2022 outbreak and …
[HTML][HTML] A genome-wide siRNA screen identifies a druggable host pathway essential for the Ebola virus life cycle
S Martin, AI Chiramel, ML Schmidt, YC Chen, N Whitt… - Genome medicine, 2018 - Springer
Background The 2014–2016 Ebola virus (EBOV) outbreak in West Africa highlighted the
need for improved therapeutic options against this virus. Approaches targeting host factors/…
need for improved therapeutic options against this virus. Approaches targeting host factors/…